 Shares of Inspire Medical Systems NYSE:INSP were flat in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 175.00 year over year to 0.88, which beat the estimate of 1.10.Revenue of 12,183,000 declined by 32.44 from the same period last year, which beat the estimate of 7,850,000.Outlook Earnings guidance hasnt been issued by the company for now.Revenue guidance hasnt been issued by the company for now.How To Listen To The Conference Call Date: Aug 04, 2020View more earnings on INSPTime: 05:00 PMET Webcast URL: Action Companys 52-week high was at 105.53Companys 52-week low was at 40.53Price action over last quarter: Up 46.22Company Overview Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea OSA. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.See more from Benzinga Stocks That Hit 52-Week Highs On Thursday Stocks That Hit 52-Week Highs On Wednesday Stocks That Hit 52-Week Highs On FridayC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 